Referenser

  1. Regionala cancercentrum i samverkan. Standardiserat vårdförlopp för cancer i urinblåsan och övre urinvägarna.  [updated 2024-05-14]. Available from: https://kunskapsbanken.cancercentrum.se/diagnoser/urinblase-och-urinvagscancer/vardforlopp/

  2. Folkhälsomyndigheten och Statens veterinärmedicinska anstalt. Swedres-Svarm 2023. Available from: https://www.sva.se/media/rrrbjnyl/swedres-svarm-2023.pdf

  3. Mancini V, Balzarro M, Illiano E, Hoznek A, Stallone G, Carrieri G. Lower urinary tract symptoms in elderly men: a simple yet comprehensive approach. Gerontology and Geriatrics [Internet]. 2018-12-15 [cited 2024-06-12];66(4):245-52. Available from: https://www.jgerontology-geriatrics.com/article/view/79

  4. Hooton TM, Bradley SF, Cardenas DD, Colgan R, Geerlings SE, Rice JC, et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis. 2010;50(5):625-63.

  5. Ulleryd P, Zackrisson B, Aus G, Bergdahl S, Hugosson J, Sandberg T. Prostatic involvement in men with febrile urinary tract infection as measured by serum prostate-specific antigen and transrectal ultrasonography. BJU Int. 1999;84(4):470-4.

  6. Sandberg T, Skoog G, Hermansson AB, Kahlmeter G, Kuylenstierna N, Lannergård A, et al. Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: a randomised, open-label and double-blind, placebo-controlled, non-inferiority trial. Lancet. 2012;380(9840):484-90.

  7. Lafaurie M, Chevret S, Fontaine JP, Mongiat-Artus P, de Lastours V, Escaut L, et al. Antimicrobial for 7 or 14 Days for Febrile Urinary Tract Infection in Men: A Multicenter Noninferiority Double-Blind, Placebo-Controlled, Randomized Clinical Trial. Clin Infect Dis. 2023;76(12):2154-62.